CIK 0001787306 · Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812974255
- Phone
- 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,318,251
- in 11 filings, $2.1M under 10b5-1 plans
Net −$3,318,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Welgus Howard G. Director | Sale 10b5-1 | −4,730 | $24.18 | $114K | 35,841 |
| 2026-09-15 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −822 | 6,574 | ||
| 2026-09-15 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,019 | 8,144 | ||
| 2026-09-15 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,255 | 18,032 | ||
| 2026-09-08 | Matsuda Masaru See Remarks | Sale 10b5-1 | −9,989 | $25.03 | $250K | 116,182 |
| 2026-08-27 | Curran Terrie Director | Option exercise | +11,148 | $7.51 | $84K | 34,674 |
| 2026-08-27 | Curran Terrie Director | Sale | −11,148 | $25.03 | $279K | 23,526 |
| 2026-08-27 | Curran Terrie Director | Option exercise | +27,052 | $8.63 | $233K | 50,578 |
| 2026-08-27 | Curran Terrie Director | Sale | −27,052 | $25.03 | $677K | 23,526 |
| 2026-08-27 | Curran Terrie Director | Option exercise · Stock Option (right to buy) | −11,148 | 0 | ||
| 2026-08-27 | Curran Terrie Director | Option exercise · Stock Option (right to buy) | −27,052 | 0 | ||
| 2026-08-20 | Curran Terrie Director | Option exercise | +1,072 | $7.51 | $8K | 24,598 |
| 2026-08-20 | Curran Terrie Director | Sale | −1,072 | $26.04 | $28K | 23,526 |
| 2026-08-20 | Curran Terrie Director | Option exercise · Stock Option (right to buy) | −1,072 | 11,148 | ||
| 2026-08-19 | Burnett Patrick See Remarks | Sale | −1,697 | $27.00 | $46K | 117,592 |
| 2026-08-17 | Welgus Howard G. Director | Option exercise 10b5-1 | +822 | $6.52 | $5K | 37,931 |
| 2026-08-17 | Welgus Howard G. Director | Option exercise 10b5-1 | +1,019 | $7.51 | $8K | 38,950 |
| 2026-08-17 | Welgus Howard G. Director | Option exercise 10b5-1 | +2,255 | $8.63 | $19K | 41,205 |
| 2026-08-17 | Welgus Howard G. Director | Sale 10b5-1 | −4,730 | $26.18 | $124K | 36,475 |
| 2026-08-17 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −822 | 7,396 |
Page 2 of 13 · 241 trades